The Market Research on Digital Therapeutics, By Considering useful aspects like; Application, End Users- Global Future Forecast till 2021, published by MarketsandMarkets™, the report studies the global Digital Therapeutics market over the forecast period of 2017 to 2021. The market is projected to reach USD 457.9 Million by 2021 at a CAGR of 27.7%.
North America dominates the digital therapeutics market, with the U.S. accounting for the major share and highest CAGR. This can be attributed to the growing incidence of chronic diseases, government initiatives to support technological advancements in digital therapeutics, gradually improving reimbursement structure for digital therapeutics solutions, and a growing influx of new startup companies in the market as a result of increasing investments in the digital therapeutics field. For instance, in July 2014, Proteus Digital Health (U.S.) secured an investment of USD 172 million from a list of institutional investors for the manufacturing and development of its digital medicine products.
The Digital Therapeutics market is fragmented with the presence of emerging players;
Proteus Digital Health, Inc. (U.S.), Omada Health Inc. (U.S.), WellDoc Inc. (U.S.), Livongo Health (U.S.), Noom Inc. (U.S.), Ginger.io Inc. (U.S.), Propeller Health (U.S.), 2Morrow Inc. (U.S.), Canary Health Inc. (U.S.), and Mango Health, Inc. (U.S.)…..Read More
Request a Sample Copy of “Digital Therapeutics Market”:
https://www.marketsandmarkets.com/requestsample.asp?id=51646724
Digital Therapeutics Market, by Sales Channel
- B2C
- B2B
Digital Therapeutics Market, by Application
- Preventive
- Treatment/Care
Digital Therapeutics Market, by Region;
- North America (US, Canada)
- Europe (UK, Germany, Others)
- Asia
- Rest of the World
For any queries Speak to our Analyst:
https://www.marketsandmarkets.com/speaktoanalyst.asp?id=51646724
Major Key Points from Table of Content:
Introduction.
Research Methodology.
Digital Therapeutics Market, By Sales Channel.
Digital Therapeutics Market, By Application.
Competitive Landscape.
Company Profiles.
The Objectives Covered in This Research Report:
- To define, describe, and forecast the global Digital Therapeutics market based on product, application, end user, and region
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities and industry-specific challenges)
- To strategically analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for the market leaders
Major Key Points from List of Tables:
- North America: Market Size for B2B Sales Channel, By Country, 2014-2021 (USD Million)
- Market Size for Pharmaceutical Companies, By Region, 2014-2021 (USD Thousand)
- North America: Market Size for Other Buyers, By Country, 2014-2021 (USD Thousand)
- Europe: Market Size for Prediabetes, By Country, 2014–2021 (USD Thousand)
- Canada: Market Size for Preventive Applications, By Disorder, 2014–2021 (USD Million)
- Europe: Market Size for Preventive Applications, By Disorder, 2014–2021 (USD Million)
- K.: Market Size, By Application, 2014–2021 (USD Million)……. Click To Read Full Toc
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownload.asp?id=51646724
Major Key Points from List of Figures (Consist of 36 Figures):
- Caregivers Segment to Register Significant Growth During the Forecast Period
- Payers to Dominate the Digital Therapeutics Market During the Forecast Period
- Venture Capital Investments and Supporting Government Initiatives: Major Factors Driving Market Growth
- Solutions for Treatment/Care Segment to Dominate the Digital Therapeutics Market.
- Caregivers to Be the Largest Segment of the Market
